Skip to content
healthcare.dev

Olanzapine

NDC 0527-3161, Olanzapine, tablet, orally disintegrating, from Lannett Company, Inc..

Product NDC
0527-3161
Status
Listed
Labeler
Lannett Company, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208146
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0527-3161 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE5 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
0527-3161-320052731613230 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0527-3161-32)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/002dd00f-7946-ea4f-e063-6294a90a5916

Use it

Look up 0527-3161 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0527-3161 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0527-3161. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.